Tillett Caroline

SEC source: 0001944048-26-000155 · wk-form4_1791335143.xml · nonDerivative · entry 2

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,709.15

F2 · shares: Shares withheld for payment of taxes.

SEC source: 0001944048-26-000155 · wk-form4_1791335143.xml · nonDerivative · entry 1

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,180.15

F1 · shares: Represents the distribution of shares of common stock upon satisfaction of the performance criteria applicable to Performance Share Units (PSUs) granted on October 2, 2023. The PSUs vested at 100% of the target award and include dividend equivalents accrued during the three-year performance period.

SEC source: 0001944048-26-000047 · wk-form4_1772662455.xml · derivative · entry 1

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,525

Underlying: Common Stock · 63,525 shares

Expires not disclosed

F1 · derivative.exercise_price: These units correspond 1 for 1 with the Company's common stock.

F2 · derivative.exercise_date: This award vests in three equal installments on 03/02/2027, 03/02/2028, and 03/02/2029, subject to the reporting person's continued service through such vesting date.

F2 · derivative.expiration_date: This award vests in three equal installments on 03/02/2027, 03/02/2028, and 03/02/2029, subject to the reporting person's continued service through such vesting date.

SEC source: 0001944048-25-000226 · wk-form4_1766011702.xml · derivative · entry 12

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,740.09

Underlying: Common Stock · 3,371.58 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: These units correspond 1 for 1 with the Company's common stock.

F10 · derivative.exercise_date: This award was scheduled to vest in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date but the vesting of the portion reflected herein was accelerated from 03/10/2026 in connection with the Section 280G Mitigation.

F10 · derivative.expiration_date: This award was scheduled to vest in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date but the vesting of the portion reflected herein was accelerated from 03/10/2026 in connection with the Section 280G Mitigation.

F4 · derivative.underlying_shares: This award will be subject to clawback in the event it is determined that the Reporting Person would not have ultimately vested in the award notwithstanding the acceleration reflected herein.

F9 · balance_after: Includes RSUs acquired as dividend equivalents.

SEC source: 0001944048-25-000226 · wk-form4_1766011702.xml · derivative · entry 11

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,399.16

Underlying: Common Stock · 4,399.06 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: These units correspond 1 for 1 with the Company's common stock.

F8 · derivative.exercise_date: This award was scheduled to vest in three equal installments on 03/05/2025, 03/05/2026, and 03/05/2027, subject to the reporting person's continued service through such vesting date but the vesting of the portion reflected herein was accelerated from 03/05/2026 in connection with the 280G Mitigation.

F8 · derivative.expiration_date: This award was scheduled to vest in three equal installments on 03/05/2025, 03/05/2026, and 03/05/2027, subject to the reporting person's continued service through such vesting date but the vesting of the portion reflected herein was accelerated from 03/05/2026 in connection with the 280G Mitigation.

F4 · derivative.underlying_shares: This award will be subject to clawback in the event it is determined that the Reporting Person would not have ultimately vested in the award notwithstanding the acceleration reflected herein.

F9 · balance_after: Includes RSUs acquired as dividend equivalents.

SEC source: 0001944048-25-000226 · wk-form4_1766011702.xml · derivative · entry 10

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,994 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: These RSUs were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer, were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value.

F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer, were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value.

F6 · derivative.exercise_date: This award was scheduled to vest in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date but the vesting of the portion reflected herein was accelerated from 02/13/2026 in connection with the Section 280G Mitigation.

F6 · derivative.expiration_date: This award was scheduled to vest in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date but the vesting of the portion reflected herein was accelerated from 02/13/2026 in connection with the Section 280G Mitigation.

F4 · derivative.underlying_shares: This award will be subject to clawback in the event it is determined that the Reporting Person would not have ultimately vested in the award notwithstanding the acceleration reflected herein.

SEC source: 0001944048-25-000226 · wk-form4_1766011702.xml · derivative · entry 9

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,158 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 2023, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level.

F2 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 2023, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level.

F3 · derivative.exercise_date: This award was scheduled to vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date but vesting was accelerated in order to mitigate the adverse impact to the Issuer and the Reporting Person of Section 280G of the Internal Revenue Code in connection with the pending transaction between the Issuer and Kimberly-Clark Corporation ("Section 280G Mitigation").

F3 · derivative.expiration_date: This award was scheduled to vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date but vesting was accelerated in order to mitigate the adverse impact to the Issuer and the Reporting Person of Section 280G of the Internal Revenue Code in connection with the pending transaction between the Issuer and Kimberly-Clark Corporation ("Section 280G Mitigation").

F4 · derivative.underlying_shares: This award will be subject to clawback in the event it is determined that the Reporting Person would not have ultimately vested in the award notwithstanding the acceleration reflected herein.

SEC source: 0001944048-25-000226 · wk-form4_1766011702.xml · nonDerivative · entry 8

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,448.15

F1 · shares: Shares withheld for payment of taxes upon vesting of Restricted Stock Units ("RSUs").

SEC source: 0001944048-25-000226 · wk-form4_1766011702.xml · nonDerivative · entry 7

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,173.15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001944048-25-000226 · wk-form4_1766011702.xml · nonDerivative · entry 6

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,801.57

F1 · shares: Shares withheld for payment of taxes upon vesting of Restricted Stock Units ("RSUs").

SEC source: 0001944048-25-000226 · wk-form4_1766011702.xml · nonDerivative · entry 5

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,052.57

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001944048-25-000226 · wk-form4_1766011702.xml · nonDerivative · entry 4

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,653.51

F1 · shares: Shares withheld for payment of taxes upon vesting of Restricted Stock Units ("RSUs").

SEC source: 0001944048-25-000226 · wk-form4_1766011702.xml · nonDerivative · entry 3

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,185.51

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001944048-25-000226 · wk-form4_1766011702.xml · nonDerivative · entry 2

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,191.51

F1 · shares: Shares withheld for payment of taxes upon vesting of Restricted Stock Units ("RSUs").

SEC source: 0001944048-25-000226 · wk-form4_1766011702.xml · nonDerivative · entry 1

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,037.51

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001944048-25-000212 · wk-form4_1764799581.xml · derivative · entry 3

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,538.86

Underlying: Common Stock · 1,538.75 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: These units correspond 1 for 1 with the Company's common stock.

F3 · derivative.exercise_date: This award vests in three equal installments on 12/01/2024, 12/01/2025, and 12/01/2026, subject to the reporting person's continued service through the vesting date.

F3 · derivative.expiration_date: This award vests in three equal installments on 12/01/2024, 12/01/2025, and 12/01/2026, subject to the reporting person's continued service through the vesting date.

F4 · balance_after: Includes RSUs acquired in dividend reinvestment transactions.

SEC source: 0001944048-25-000212 · wk-form4_1764799581.xml · nonDerivative · entry 2

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,879.51

F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units (RSUs).

SEC source: 0001944048-25-000212 · wk-form4_1764799581.xml · nonDerivative · entry 1

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,667.51

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: These units correspond 1 for 1 with the Company's common stock.

SEC source: 0001944048-25-000088 · wk-form4_1741820029.xml · derivative · entry 2

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,837

Underlying: Common Stock · 81,837 shares

Expires 2035-03-10

F2 · derivative.exercise_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date.

SEC source: 0001944048-25-000088 · wk-form4_1741820029.xml · derivative · entry 1

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,807

Underlying: Common Stock · 9,807 shares

Expires not disclosed

F1 · derivative.exercise_price: These units correspond 1 for 1 with the Company's common stock.

F2 · derivative.exercise_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date.

F2 · derivative.expiration_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date.

SEC source: 0001944048-25-000068 · wk-form4_1741384985.xml · derivative · entry 3

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,533.13

Underlying: Common Stock · 4,267.56 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: These units correspond 1 for 1 with the Company's common stock.

F3 · derivative.exercise_date: This award vests in three equal installments on 03/05/2025, 03/05/2026, and 03/05/2027, subject to the reporting person's continued service through such vesting date.

F3 · derivative.expiration_date: This award vests in three equal installments on 03/05/2025, 03/05/2026, and 03/05/2027, subject to the reporting person's continued service through such vesting date.

F4 · balance_after: Includes RSUs acquired as dividend equivalents.

SEC source: 0001944048-25-000068 · wk-form4_1741384985.xml · nonDerivative · entry 2

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,128.76

F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units (RSUs).

SEC source: 0001944048-25-000068 · wk-form4_1741384985.xml · nonDerivative · entry 1

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,657.76

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: These units correspond 1 for 1 with the Company's common stock.

SEC source: 0001944048-25-000020 · wk-form4_1739921354.xml · derivative · entry 9

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,121 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 2023, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level.

F1 · derivative.exercise_price: The Restricted Share Units (RSUs) converted into shares of Common Stock on a one-for-one basis upon vesting.

F4 · derivative.exercise_date: This award vested in full on 02/14/2025.

F4 · derivative.expiration_date: This award vested in full on 02/14/2025.

SEC source: 0001944048-25-000020 · wk-form4_1739921354.xml · derivative · entry 8

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,645 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Share Units (RSUs) converted into shares of Common Stock on a one-for-one basis upon vesting.

F4 · derivative.exercise_date: This award vested in full on 02/14/2025.

F4 · derivative.expiration_date: This award vested in full on 02/14/2025.

SEC source: 0001944048-25-000020 · wk-form4_1739921354.xml · nonDerivative · entry 6

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,390.2

F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs.

SEC source: 0001944048-25-000020 · wk-form4_1739921354.xml · nonDerivative · entry 5

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,625.2

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Restricted Share Units (RSUs) converted into shares of Common Stock on a one-for-one basis upon vesting.

SEC source: 0001944048-25-000020 · wk-form4_1739921354.xml · nonDerivative · entry 4

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,504.2

F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs.

SEC source: 0001944048-25-000020 · wk-form4_1739921354.xml · nonDerivative · entry 3

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,123.2

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Restricted Share Units (RSUs) converted into shares of Common Stock on a one-for-one basis upon vesting.

SEC source: 0001944048-25-000020 · wk-form4_1739921354.xml · derivative · entry 7

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,994

Underlying: Common Stock · 3,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Share Units (RSUs) converted into shares of Common Stock on a one-for-one basis upon vesting.

F3 · derivative.exercise_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date.

F3 · derivative.expiration_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date.

SEC source: 0001944048-25-000020 · wk-form4_1739921354.xml · nonDerivative · entry 2

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,478.2

F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs.

SEC source: 0001944048-25-000020 · wk-form4_1739921354.xml · nonDerivative · entry 1

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,490.2

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Restricted Share Units (RSUs) converted into shares of Common Stock on a one-for-one basis upon vesting.

SEC source: 0001944048-24-000175 · wk-form4_1733269105.xml · derivative · entry 3

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,994.42

Underlying: Common Stock · 1,498.2 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Share Units (RSUs) converted into shares of Common Stock on a one-for-one basis upon vesting.

F3 · derivative.exercise_date: This award vests in three equal installments on 12/01/2024, 12/01/2025, and 12/01/2026, subject to the reporting person's continued service through the vesting date.

F3 · derivative.expiration_date: This award vests in three equal installments on 12/01/2024, 12/01/2025, and 12/01/2026, subject to the reporting person's continued service through the vesting date.

F4 · balance_after: Includes shares acquired in dividend reinvestment transactions.

SEC source: 0001944048-24-000175 · wk-form4_1733269105.xml · nonDerivative · entry 2

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,490.2

F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs.

SEC source: 0001944048-24-000175 · wk-form4_1733269105.xml · nonDerivative · entry 1

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,257.2

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Restricted Share Units (RSUs) converted into shares of Common Stock on a one-for-one basis upon vesting.

SEC source: 0001944048-24-000072 · wk-form4_1709853963.xml · derivative · entry 2

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,009

Underlying: Common Stock · 111,009 shares

Expires 2034-03-05

F2 · derivative.exercise_date: This award vests in three equal installments on 03/05/2025, 03/05/2026, and 03/05/2027, subject to the reporting person's continued service through such vesting date.

SEC source: 0001944048-24-000072 · wk-form4_1709853963.xml · derivative · entry 1

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,340

Underlying: Common Stock · 12,340 shares

Expires not disclosed

F1 · derivative.exercise_price: These units correspond 1 for 1 with the Company's common stock.

F2 · derivative.exercise_date: This award vests in three equal installments on 03/05/2025, 03/05/2026, and 03/05/2027, subject to the reporting person's continued service through such vesting date.

F2 · derivative.expiration_date: This award vests in three equal installments on 03/05/2025, 03/05/2026, and 03/05/2027, subject to the reporting person's continued service through such vesting date.

SEC source: 0001944048-24-000044 · wk-form4_1708036023.xml · derivative · entry 3

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,994

Underlying: Common Stock · 3,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting.

F3 · derivative.exercise_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date.

F3 · derivative.expiration_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date.

SEC source: 0001944048-24-000044 · wk-form4_1708036023.xml · nonDerivative · entry 2

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,759

F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units.

SEC source: 0001944048-24-000044 · wk-form4_1708036023.xml · nonDerivative · entry 1

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,787

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting.

SEC source: 0001944048-24-000025 · wk-form4_1707783251.xml · derivative · entry 6

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,675 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 2023 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value.

F5 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 2023 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value.

F4 · derivative.exercise_date: This award is fully vested.

F4 · derivative.expiration_date: This award is fully vested.

SEC source: 0001944048-24-000025 · wk-form4_1707783251.xml · derivative · entry 5

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 21,321 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years.

F3 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years.

F4 · derivative.exercise_date: This award is fully vested.

F4 · derivative.expiration_date: This award is fully vested.

SEC source: 0001944048-24-000025 · wk-form4_1707783251.xml · nonDerivative · entry 4

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,787

F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units.

SEC source: 0001944048-24-000025 · wk-form4_1707783251.xml · nonDerivative · entry 3

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,035

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting.

SEC source: 0001944048-24-000025 · wk-form4_1707783251.xml · nonDerivative · entry 2

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,360

F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units.

SEC source: 0001944048-24-000025 · wk-form4_1707783251.xml · nonDerivative · entry 1

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,321

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting.

SEC source: 0001944048-23-000123 · wk-form4_1702332825.xml · derivative · entry 2

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,705

Underlying: Common Stock · 39,705 shares

Expires 2033-12-07

F2 · derivative.exercise_date: This award vests in three equal installments on 12/01/2024, 12/01/2025, and 12/01/2026, subject to the reporting person's continued service through such vesting date.

SEC source: 0001944048-23-000123 · wk-form4_1702332825.xml · derivative · entry 1

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,324

Underlying: Common Stock · 4,324 shares

Expires not disclosed

F1 · derivative.exercise_price: These units correspond 1 for 1 with the Company's common stock.

F2 · derivative.exercise_date: This award vests in three equal installments on 12/01/2024, 12/01/2025, and 12/01/2026, subject to the reporting person's continued service through such vesting date.

F2 · derivative.expiration_date: This award vests in three equal installments on 12/01/2024, 12/01/2025, and 12/01/2026, subject to the reporting person's continued service through such vesting date.

SEC source: 0001944048-23-000087 · wk-form4_1696451367.xml · derivative · entry 1

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,957

Underlying: Common Stock · 113,957 shares

Expires 2033-10-02

F1 · derivative.exercise_date: This award will vest in full on 10/02/2026, subject to the reporting person's continued service through the vesting date.

SEC source: 0001944048-23-000060 · wk-form4_1693002588.xml · derivative · entry 9

Tillett Caroline · CIK 0001966949 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,348

Underlying: Common Stock · 73,348 shares

Expires 2031-02-08

F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value.

F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date.